ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,799, issued on Jan. 20, was assigned to Rugen Holdings (Cayman) Ltd. (Grand Cayman, Cayman Islands).

"Treatment of autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders" was invented by Gideon Shapiro (Gainesville, Fla.) and Dorothy G. Flood (West Chester, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods for treating NMDA receptor-mediated disorders by administering certain NR2B subunit-selective NMDA (N methyl-D aspartate) antagonists. NMDA receptor-mediated disorders include autism spectrum disorders, obsessive-compulsive disorder and anxiety disorders."

The patent was filed on Sept. 7, 2023, under...